Learn how telemedicine is revolutionizing decentralized clinical trials (DCTs) by improving patient engagement, cutting costs, reducing dropout rates, and expanding diversity. Discover how BioBoston Consulting can help you leverage these advancements.
Decentralized clinical trials (DCTs) harness the power of telemedicine to create benefits for medical research by streamlining systems, increasing access, and improving patient engagement. With the healthcare industry quickly moving to adopt these innovations, it is important to know how telemedicine profoundly affects decentralized clinical trials. In this article, we examine five statistics and trends that reveal the role telemedicine has played and will continue to play in transforming DCTs. We will focus on five statistics that reveal the role that telemedicine has played and will continue to play in transforming DCTs, which provides a more in-depth view here that can be used by people, biotech and pharmaceutical and life science consulting firms in Boston.
Boosted Patient Engagement by More Than 30%
With practises like telemedicine erasing geographical boundaries and allowing patients easy access to clinical trials, location ceases to be a barrier to entry. The improved accessibility has contributed to a more than 30% increase in patient enrollment in some studies. For biotech consulting firms Boston, this trend is a valuable opportunity to be able to advise clients on how they can use telehealth platforms to expand their reach and support trial recruitment.
Cut Drop-out Rates in Half
Patient retention is one of the biggest hurdles in a clinical trial. One clear example is the use of telemedicine, which enables ongoing, straightforward engagement of patients and researchers, and has been associated with a reduction in dropout rates by as much as 50%. Telehealth can play a key role in maintaining higher retention rates during clinical trials thereby making them successful.
Cutting Costs by Up to 25%
By using telemedicine, decentralized clinical trials can also drive down costs by eliminating both unnecessary in-person site visits, yielding less administrative overhead and low patient travel costs. Research has shown that using telemedicine can reduce total trial costs by as much as 25%. This cost-effectiveness is especially enticing for biopharma consulting firms in Boston that serve budget optimization recommendations through new technologies as a signature service.
The Improved Data Gathering and Real-Time Monitoring
Telemedicine facilitates the collection of data on real time and its monitoring, enhancing the accuracy and timeliness of clinical trial data. They also aid in continuous collection of health data by researchers, which in turn also increases the reliability of trial outcomes. Boston-based life science consulting firms are in prime position to assist clients with incorporating these technologies into their respective trial designs, ensuring data quality and compliance with regulatory requirements.
Reaching a Wider Range of People
Another factor is that telemedicine encourages broader diversity by not requiring patients to travel to clinical trial sites. This diversity is essential to guarantee that the findings from clinical studies are relevant and generalizable to a wider population, which ultimately aids in the discovery of more effective and equitable healthcare solutions. Boston-based biotech consultants can capitalize on this trend through assisting clients to structure and design trials that better reflect the diversity of patients that exist in the general population’ thus having further generalizability of their findings.
Conclusion
Decentralized clinical trials through the use of telemedicine are a breakthrough in medical research. As a solution, telemedicine is emerging as a much bigger win with marked enhancements in patient engagement, retention, cost effectiveness, data gathering, and diversity. Boston-based consulting firms are ideally situated to assist their clients, be they in biotech, pharma, life science, biopharma, biotechnology, and in helping those clients navigate and seize the opportunities presented by these advancements. As a result of being at the forefront of these trends, consulting firms can offer their expertise to help usher in a new era of clinical trials and innovation.
Call BioBoston Consulting now or visit our website to find out how we can help your company.
